DNA polymerase alpha subunit B (POLA2) is a vital component of the DNA polymerase alpha complex, which plays a pivotal role in DNA replication initiation. The enzyme DNA polymerase alpha possesses both polymerase and primase activities, necessary for synthesizing short RNA-DNA hybrid primers on the lagging strand during DNA replication. POLA2 acts as an accessory factor, contributing to the complex's stability and activity.This protein is essential for the proper assembly of the polymerase alpha complex and is required for the initiation of DNA synthesis on both the leading and lagging strands during the S phase of the cell cycle. It works in coordination with the catalytic subunit of the enzyme to ensure accurate and efficient DNA replication, which is fundamental to cell division and the maintenance of genomic integrity.
POLA2's activity is tightly regulated, as errors in DNA replication can lead to mutations and genomic instability, contributing to the development of various diseases, including cancer. Understanding the function and regulation of POLA2 and the polymerase alpha complex as a whole is critical for deciphering the molecular mechanisms of cell proliferation and the maintenance of genetic information.Research on POLA2 and other components of the replication machinery continues to be a significant area of study, with implications for understanding cell cycle control, the response to DNA damage, and the underlying causes of diseases associated with replication stress. Insights into POLA2 may also offer potential targets for cancer, where the fidelity of DNA replication is often compromised.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Induces replication stress, potentially upregulating POLA2 as part of the DNA damage response. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Inhibits DNA polymerases, possibly increasing POLA2 expression to overcome replication blockades. | ||||||
L-Mimosine | 500-44-7 | sc-201536A sc-201536B sc-201536 sc-201536C | 25 mg 100 mg 500 mg 1 g | $36.00 $88.00 $220.00 $436.00 | 8 | |
Induces cell cycle arrest, which may enhance POLA2 expression as cells prepare for DNA synthesis. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Inhibits dihydrofolate reductase, causing DNA synthesis stress, possibly leading to POLA2 upregulation. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Causes thymine deficiency, potentially increasing POLA2 expression to compensate for impaired DNA synthesis. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
DNA damage inducer, could upregulate POLA2 as part of the cellular attempt to repair and replicate DNA. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Generates DNA breaks, potentially stimulating POLA2 expression for DNA repair processes. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Forms DNA crosslinks, which might lead to increased POLA2 expression as cells activate DNA repair mechanisms. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Topoisomerase inhibitor, could upregulate POLA2 as cells respond to replication stress. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Causes oxidative DNA damage, potentially enhancing POLA2 expression during the DNA damage response. | ||||||